Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573946 · ClinicalTrials.gov registry record · NA
VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)
A NA study of Bone Density and Fractures, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 25,871
- Enrollment target
- 1
- Study location
NCT04573946: Active NA study of Bone Density and Fractures, sponsored by Brigham and Women's Hospital.
NCT04573946 is a NA study of Bone Density and Fractures that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 25,871 participants, above the 71-participant average among 7 other Bone Density trials with a reported enrollment target (36338% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04573946, a NA study of Bone Density and Fractures, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25,871 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitamin D supplements are widely promoted for bone health. Both vitamin D and vitamin K are important for deposition of calcium in bone, but little is known about the relationship of vitamin K status and bone health.
Primary Outcome
The effect of low vitamin K status (with or without vitamin D supplementation) on the number of new total, non-vertebral and hip fractures.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Fish oil placebo
- DRUG Omega-3 fatty acids (fish oil)
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,871 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT04573946 still lists
NCT04573946 is an interventional study that assigns participants to a tested intervention. Its 25,871 participants enrollment target places it among the larger protocols in the corpus, above the 71-participant average among 7 other Bone Density trials with a reported enrollment target (36338% higher).
The record links to 3 conditions, with Bone Density appearing as the primary indexed condition, and to 4 interventions - of which Vitamin D3 is the first listed.
NCT04573946 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04573946 about?
NCT04573946 is a clinical study titled "VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)". Vitamin D supplements are widely promoted for bone health. Both vitamin D and vitamin K are important for deposition of calcium in bone, but little is known about the relationship of vitamin K status and bone health.
What is the current status of trial NCT04573946?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25,871 participants. The study started on 2019-07-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04573946 study?
This clinical trial studies the following conditions: Bone Density, Fractures, Bone Health.
What interventions are being tested in trial NCT04573946?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), Omega-3 fatty acids (fish oil) (DRUG).
Who is sponsoring clinical trial NCT04573946?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04573946 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Density
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults
ACTIVE NOT RECRUITING · NA
-
The Effect of Weight Loss and Dietary Protein Intake on Bone
COMPLETED · NA
-
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
RECRUITING
-
Role of Estrogen on Skeletal Outcomes in FHA
RECRUITING · Phase 2
-
Low Energy Availability, Menstrual Irregularity, and Low Bone Mass
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI